Comparison of Gabapentin With Doxepin in the Management of Uremic Pruritus
Status:
Completed
Trial end date:
2018-10-08
Target enrollment:
Participant gender:
Summary
This is a single blind randomized trial to compare efficacy and side effects of Gabapentin
with Doxepin. Hemodialysis patients with uremic pruritus at one dialysis center of Saint
George Hospital University Medical Centre were included in this study. Patients were divided
into 2 groups to receive either 10 mg Doxepin daily or Gabapentin at a dose of 100mg after
each hemodialysis session (increased as tolerated) for 4 weeks, after which patients were
treated reversley. Pruritus severity and its effect on quality of life will be assessed by
using visual analog scale (VAS), 5-D pruritus scale and dermatology life quality index
(DLQI). Include patients will have to fill these forms at baseline and at end of week1, week2
and week4